OakChart

LifeMD Inc

LFMDHealthcare·Health Information Services·USA·Micro·NASD·Nov 11 • 9:55 AM ET

1.75+0.01 (0.86%)
2026-11-11 15:55 CET
Market cap
83.87 USD m
Revenue, TTM
204.48 USD m
Net income, TTM
-24.37 USD m
Free cash flow, TTM
-11.03 USD m
EPS diluted, TTM
-0.52
P/E
-
Compare

Price

LFMD against its 20, 50 and 200-day averages
2050200miss
2.003.004.005.002.5M5.0MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26LFMDclose 1.7620-day 2.2050-day 2.65200-day 3.611.76

71.2% under 6.09 on 30 Oct 2025. Last 15 sessions, 46.9% high to low

Profile

LFMD
52-week range, 1% of the way up
1.705.38

LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded by Justin Schreiber on May 24, 1994 and is headquartered in New York, NY.

IndexRUT
Employees389
IPOOct 21, 2003
Beta2.20
ATR, 14d0.19
Rel volume1.53
Short float18.48%
Insider own18.73%
Inst own50.61%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap84.59M
Enterprise Value65.47M
Income-24.37M
Sales204.48M
Book/sh0.17
Cash/sh0.52
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees389
IPOOct 21, 2003

Ratios

P/E-
Forward P/E-
PEG-
P/S0.41
P/B10.53
P/C3.36
P/FCF-
EV/EBITDA-
EV/Sales0.32
Quick Ratio0.84
Current Ratio0.90
Debt/Eq0.76
LT Debt/Eq0.67
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.52
EPS next Y-0.09
EPS next Q-0.14
EPS this Y-307.43%
EPS next Y82.37%
EPS next 5Y-15.28%
EPS past 3/5Y47.57% 44.86%
Sales past 3/5Y17.69% 39.08%
EPS Y/Y TTM-143.95%
Sales Y/Y TTM-16.73%
EPS Q/Q-156.23%
Sales Q/Q-24.01%
EarningsNov 09 BMO
EPS/Sales Surpr.-9.81% -3.78%

Ownership

Insider Own18.73%
Insider Trans0.00%
Inst Own50.61%
Inst Trans9.79%
ROA-31.25%
ROE-674.34%
ROIC-160.04%
Gross Margin82.43%
Oper. Margin-9.35%
Profit Margin-11.92%
SMA20-20.16%
SMA50-33.74%
SMA200-51.32%
Trades-

Technical

Shs Outstand47.82M
Shs Float39.17M
Short Float18.48%
Short Ratio9.44
Short Interest7.24M
52W High5.38 -67.35%
52W Low1.70 3.54%
Volatility14.54% 7.97%
ATR (14)0.19
RSI (14)30.68
Beta2.20
Rel Volume1.53
Avg Volume767.07K
Volume129,735

Performance

Perf Week-28.37%
Perf Month-28.95%
Perf Quarter-49.28%
Perf Half Y-61.34%
Perf YTD-48.53%
Perf Year-65.32%
Perf 3Y-74.49%
Perf 5Y-63.59%
Perf 10Y35.00%
Recom1.00
Target Price8.12
Prev Close1.74
Price1.75
Change %0.86%

Analyst ratings

latest 10 of 12
DateActionAnalystRating changeTargetImplied
Sep 11, 2026ResumedRB. Riley SecuritiesBuy$8+355.8%
Mar 16, 2026UpgradeMMizuhoNeutral → Outperform$8+355.8%
Jun 18, 2025ReiteratedBBTIG ResearchBuy$15 → $18+925.6%
Dec 10, 2024InitiatedLLake StreetBuy$12+583.8%
Dec 04, 2024InitiatedMMizuhoNeutral$7+298.9%
Aug 23, 2024ResumedRB. Riley SecuritiesBuy$11+526.8%
Jun 05, 2024InitiatedKKeyBanc Capital MarketsOverweight$12+583.8%
Nov 30, 2023InitiatedCCraig HallumBuy$10+469.8%
Jul 21, 2023InitiatedCCantor FitzgeraldOverweight$7+298.9%
Jul 03, 2023InitiatedHH.C. WainwrightBuy$9+412.8%

Peers

Mkt cap
TickerCompanyMkt cap
HIMSHims & Hers Health Inc4.52B
MGRXMangoceuticals Inc4.30M
WWWW International Inc127.69M
TDOCTeladoc Health Inc1.62B
AMWLAmerican Well Corp209.38M
GDRXGoodRx Holdings Inc1.21B
OMDAOmada Health Inc962.21M
DRIODarioHealth Corp26.36M
HNGEHinge Health Inc9.66B
BTMDbiote Corp62.97M

Insider trading

3 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
FRIEDEMAN JESSICAOfficerMar 23 '26Proposed Sale4.6440,000185,700Mar 23 10:47 AM
FRIEDEMAN JESSICAChief Marketing OfficerDec 09 '25Sale3.6115,00054,158205,000Dec 11 05:11 PM
FRIEDEMAN JESSICAOfficerNov 24 '25Proposed Sale4.0420,00080,800Nov 24 12:46 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
KOMPState Street SPDR S&P Kensho New Economies Composite ETFAUM: 2.46B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
IWCiShares Micro-Cap ETFAUM: 1.22B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
ITOTiShares Core S&P Total U.S. Stock Market ETFAUM: 95.28B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M

News

latest 14 of 206
  • LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026 (GlobeNewswire) -11.60%
  • LifeMD expands access to Lilly's self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwide (GlobeNewswire) -6.53%
  • LifeMD Must Prove Its Promised Second-Half Turn After A Bruising Guidance Cut (Earnings Whispers)
  • LifeMD to Report Third Quarter 2026 Financial Results on November 9 (GlobeNewswire)
  • LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire) -7.58%
  • Loading…
  • AT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD (PR Newswire)
  • UPDATE - LifeMD Reports Second Quarter 2026 Results (GlobeNewswire) -5.64% -7.61%
  • LifeMD Reports Second Quarter 2026 Results (GlobeNewswire)
  • Earnings To Watch: LifeMD Inc (LFMD) Q2 2026 -- GF Value Sees 92% Upside (GuruFocus.com)
  • LifeMD to Report Second Quarter 2026 Financial Results on August 5 (GlobeNewswire)
  • LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock (GlobeNewswire) +5.57%
  • LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED (testosterone enanthate) Injection (GlobeNewswire) -9.26%
  • LifeMD Appoints Umesh Sripad as Chief Technology Officer (GlobeNewswire) +8.18%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-08-05-0.160-0.146-0.16047.3049.167
2026Q12026-05-06-0.200-0.206-0.20450.1648.847
2025Q42026-03-090.410-0.066-0.04946.8745.827
2025Q32025-11-17-0.100-0.020-0.09960.1762.092
2025Q22025-08-05-0.060-0.008-0.06462.2266.346
2025Q12025-05-060.010-0.0530.01365.7062.467
2024Q42025-03-10-0.020-0.051-0.02164.2557.477
2024Q32024-11-07-0.140-0.118-0.14153.3953.826
2024Q22024-08-07-0.190-0.144-0.18550.7048.465
2024Q12024-05-08-0.190-0.154-0.19244.1442.595
2023Q42024-03-11-0.120-0.140-0.12344.8641.305
2023Q32023-11-08-0.200-0.087-0.20038.6138.443
2023Q22023-08-090.050-0.095-0.23135.9535.152
2023Q12023-05-120.060-0.160-0.15133.1330.811
2022Q42023-03-22-0.400-0.180-0.40528.1233.581
2022Q32022-11-10-0.030-0.210-0.26131.4131.852

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-3.165-3.090-4.43937.2937.30
2021FY-1.480-1.700-2.28792.8892.92
2022FY-1.570-1.340-1.570119.03124.49
2023FY-0.700-0.712-0.699152.55148.99
2024FY-0.530-0.553-0.595212.45205.65
2025FY0.250-0.2130.250194.06233.96
2026FY--0.519--207.61
2027FY--0.091--244.99
2028FY-0.152--280.09

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-2781148.8045.6050.97
2026Q3S2026-10-2381148.8045.6050.97
2026Q3S2026-10-2081148.8045.6051.00
2026Q3S2026-10-1481748.8045.6051.00
2026Q3S2026-09-1081748.8745.6051.00
2026Q3S2026-08-0680848.7745.6051.00
2026Q3S2026-08-0580058.5657.0060.80
2026Q3S2026-07-2781058.5657.0060.80
2026Q3S2026-07-2282058.5657.0060.80
2026Q3S2026-07-2182058.5557.0060.80
2026Q3S2026-07-0683158.5557.0060.80
2026Q3S2026-05-2483158.5557.0060.80
2026Q3S2026-05-2284358.5557.0060.80
2026Q3S2026-05-1384358.4357.0060.80

Estimate history

EPS, annual-0.144-0.225-0.317-4.439-2.287-1.57-0.699-0.595-0.226-0.5162
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.185-0.141-0.0210.013-0.064-0.099-0.049-0.204-0.165
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual3.6828.32412.46937.29492.876119.034152.547154.824194.055204.48
Period201720182019202020212022202320242025TTM
Sales, quarterly50.66253.39364.25565.69862.21860.17246.86850.16347.281
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual8.7969.05310.57823.33130.60131.4538.25642.19146.65747.82
Period201720182019202020212022202320242025MRQ
Shares, quarterly41.65741.80742.19143.5345.03846.58346.65747.5347.82
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue204.48194.06154.82152.55119.0392.8837.2912.478.32
Cost of Goods Sold Incl. D&A35.9239.2931.6626.5323.7020.839.584.182.57
Gross Profit168.56154.76123.17126.0195.3372.0427.728.295.75
Selling, General and Administrative Excl. Other175.43151.36134.91134.21128.30122.8984.4610.467.29
Research and Development4.867.356.866.062.970.780.450.220.12
Other Operating Expense12.2611.078.666.306.723.451.080.720.52
Operating Income-19.13-7.67-20.40-14.49-39.69-54.30-57.82-2.89-2.06
Interest Expense-1.362.182.601.283.021.670.760.35
Unusual Expense1.161.160.000.333.704.000.91-0.00
Net Income Before Taxes-20.42-10.19-22.58-17.41-44.66-61.32-60.40-3.65-2.41
Income Taxes0.180.050.600.430.360.010.12-0.12-0.12
Consolidated Net Income-20.60-10.23-23.18-17.84-45.02-61.32-60.52-3.53-2.29
Net Income From Continuing Operations-20.85-10.23-23.18-20.60-45.54-60.90-58.65-3.14-2.17
Net Income-24.37-10.21-24.52-23.70-48.64-61.77-63.36-3.14-1.99
EPS (Recurring)-0.49-0.21-0.60-0.69-1.49-2.18-4.39-0.32-0.22
EPS (Basic, Before Extraordinaries)-0.52-0.23-0.60-0.70-1.57-2.29-4.44-0.32-0.22
EPS (Diluted)-0.52-0.23-0.60-0.70-1.57-2.29-4.44-0.32-0.22
EBITDA-10.15-0.36-14.21-7.89-35.92-53.43-57.42-2.55-1.86
Non-Operating Income (Expense)0.130.000.000.000.000.000.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.868.299.679.8710.858.8113.360.540.22
Price To Sales Ratio0.970.791.321.840.501.132.500.460.74
Gross Margin82.4379.7579.5582.6180.0977.5774.3266.5069.12
Operating Margin-9.35-3.95-13.18-9.50-33.34-58.47-155.04-23.18-24.70
Net Margin-11.92-5.26-15.83-15.54-40.86-66.51-169.90-25.16-23.85
Shares Outstanding47.8246.6642.1938.2631.4530.6023.3310.589.05
Market Capitalization83.8783.87128.34128.34128.34128.34128.346.086.34

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue47.2850.1646.8760.1762.2265.7064.2553.39
Cost of Goods Sold Incl. D&A9.617.608.5210.1910.6611.7212.267.82
Gross Profit37.6742.5638.3549.9851.5653.9851.9945.58
Selling, General and Administrative Excl. Other41.7648.3136.4548.9149.4348.9248.1848.15
Research and Development0.080.121.822.852.742.682.412.61
Other Operating Expense3.043.183.003.043.032.512.802.11
Operating Income-7.13-8.93-1.10-1.97-0.912.541.02-4.69
Interest Expense0.00--0.260.660.630.610.56
Unusual Expense0.000.000.001.160.000.000.000.00
Net Income Before Taxes-7.08-8.87-1.07-3.39-1.571.920.40-5.24
Income Taxes0.000.000.010.170.000.000.170.23
Consolidated Net Income-7.08-8.87-1.09-3.56-1.571.920.23-5.48
Net Income From Continuing Operations-7.08-8.87-1.09-3.81-2.071.38-0.11-5.13
Net Income-7.86-9.65-2.27-4.58-2.850.61-0.88-5.91
EPS (Recurring)-0.16-0.20-0.05-0.08-0.060.01-0.02-0.14
EPS (Basic, Before Extraordinaries)-0.16-0.20-0.05-0.10-0.060.01-0.02-0.14
EPS (Diluted)-0.16-0.20-0.05-0.10-0.060.01-0.02-0.14
EBITDA-5.09-6.930.851.021.925.203.57-2.13
Non-Operating Income (Expense)0.050.060.020.000.000.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.791.452.102.532.091.662.451.89
Price To Sales Ratio0.970.780.681.242.461.060.981.14
Gross Margin79.6784.8581.8283.0682.8682.1780.9285.36
Operating Margin-15.08-17.80-2.34-3.27-1.463.871.58-8.78
Net Margin-16.63-19.24-4.85-7.62-4.580.93-1.37-11.07
Shares Outstanding47.8247.5346.6646.5845.0443.5342.1941.81
Market Capitalization83.87173.19164.14321.96619.00242.54128.34128.34

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments36.7932.6533.153.9641.339.181.110.180.14
Short Term Receivables9.3110.465.282.830.981.000.100.100.13
Inventories2.772.802.763.701.621.260.951.020.68
Other Current Assets2.976.461.420.811.000.970.590.300.31
Total Current Assets51.8352.3742.6011.3144.9212.412.751.611.26
Net Property, Plant & Equipment7.717.671.071.681.990.270.020.000.00
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets10.879.3614.8112.673.020.720.681.010.00
Other Assets0.006.700.000.000.000.000.000.000.00
Total Assets70.4176.1058.4825.6749.9213.403.452.621.26
Short Term Debt Incl. Current Port. of LT Debt0.648.760.933.550.670.870.810.250.17
Accounts Payable14.1510.9011.0810.1120.6512.143.050.870.41
Other Current Liabilities26.7847.7322.7717.711.500.920.110.080.07
Total Current Liabilities41.5767.4034.7831.3722.8313.933.981.190.64
Long Term Debt5.6816.1618.000.571.180.190.030.000.00
Provision for Risks Charges0.000.000.000.440.100.100.500.600.00
Deferred Tax Liabilities-----0.000.070.00-
Other Liabilities0.000.090.130.580.000.000.000.000.00
Total Liabilities47.2583.6552.9132.9724.1014.224.581.800.64
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.004.574.113.660.000.000.00
Common Equity23.16-9.083.51-11.4022.74-2.30-0.990.900.88
Total Shareholders Equity23.16-9.083.51-6.8326.851.35-0.990.900.88
Accumulated Minority Interest0.001.532.06-0.48-1.03-2.18-0.14-0.08-0.26
Total Equity23.16-7.555.57-7.3125.82-0.82-1.130.820.62
Total Liabilities & Stockholders Equity70.4176.1058.4825.6749.9213.403.452.621.26
Book Value Per Share0.50-0.220.09-0.360.74-0.10-0.090.100.10
Tangible Book Value Per Share0.26-0.44-0.30-0.770.64-0.13-0.16-0.010.10
Full-Time Employees389336232220232562616-
Price to Book Ratio10.44-19.23-19.23-19.23-19.23-19.23-6.167.0618.19
Return on Assets-14.32-34.44-48.95-120.48-193.40-696.14-103.50-111.68-133.11
Return on Equity-115.81---454.88-431.83-32,070.47--243.49-518.95
Return on Invested Capital-24.64-302.35-95.76--217.26-3,792.86--221.19-136.74
Quick Ratio1.180.741.150.241.900.800.450.490.91
Current Ratio1.250.781.220.361.970.890.691.351.97

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-0.6815.62-20.86-17.84-45.02-61.32-60.52-3.53-1.36
Depreciation5.867.316.196.603.770.870.400.340.20
Other Funds (Non Cash)-9.55-6.8014.8315.1519.5118.2439.201.380.51
Funds from Operations-4.3716.130.163.91-21.39-42.22-21.00-1.75-0.65
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-5.54-7.8517.354.91-1.559.138.872.00-0.26
Cash from Operating Activities-9.918.2817.518.82-22.94-33.09-12.130.25-0.91
Capital Expenditures-6.64-9.52-8.20-8.73-12.89-3.40-0.400.00-0.10
Net Assets From Acquisitions0.000.000.000.00-1.010.000.000.00-0.15
Sale of Fixed Assets and Businesses0.000.000.000.000.010.000.000.000.39
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.00-3.330.000.000.00-0.40-0.100.00
Other Sources16.4316.430.000.000.000.000.000.000.00
Cash from Investing Activities9.786.91-11.54-8.73-13.89-3.40-0.80-0.100.14
Cash Dividends Paid-3.11-3.11-3.11-3.11-3.11-0.870.000.000.00
Change in Capital Stock9.279.190.1216.300.1370.4821.080.350.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock9.279.190.1216.300.1370.4821.080.350.00
Proceedsfrom Stock Options8.728.720.0010.000.0069.3320.130.350.00
Issuance or Reduction of Debt, Net-16.67-18.72-0.3316.672.74-0.530.090.800.64
Change in Long Term Debt-16.67-18.72-0.3316.670.000.000.000.000.00
Issuance of Long Term Debt0.000.000.0021.810.000.000.000.000.00
Reduction of Long Term Debt-16.67-18.72-0.33-5.140.000.000.000.000.00
Net Financing Active Other Cash Flow-0.46-0.77-0.81-0.76-0.30-0.44-0.17-0.370.16
Other Financing Activities Uses-0.46-0.77-0.81-0.76-0.30-0.44-0.17-0.370.00
Cash from Financing Activities-10.96-13.41-4.1229.10-0.5468.6421.000.780.80
Net Change in Cash-11.091.781.8629.19-37.3732.158.070.930.04
Free Cash Flow-11.036.4116.058.62-23.30-33.33-12.130.25-0.91
Preferred Dividends (Cash Flow)--3.11-3.11-3.11-3.11-0.870.000.000.00
Price to Free Cash Flow-46.5915.7551.01---22.64-
Deferred Taxes & Investment Tax Credit-0.000.000.000.350.00-0.070.070.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments25.1434.4836.7923.7936.2334.39
Short Term Receivables11.269.869.319.247.3310.19
Inventories2.963.182.773.433.252.97
Other Current Assets2.734.192.974.622.222.42
Total Current Assets42.0851.7051.8341.0949.0349.97
Net Property, Plant & Equipment6.887.327.718.167.877.54
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets10.9311.1110.8716.7316.6716.10
Other Assets0.000.000.000.000.000.00
Total Assets59.8970.1270.4165.9873.5673.61
Short Term Debt Incl. Current Port. of LT Debt0.700.670.640.6712.5012.09
Accounts Payable18.1621.6514.1519.5524.2915.68
Other Current Liabilities27.7527.2626.7836.4426.7433.13
Total Current Liabilities46.6149.5941.5756.6663.5360.90
Long Term Debt5.325.505.685.859.5513.01
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.100.100.10
Total Liabilities51.9355.0947.2562.6273.1874.01
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity7.9715.0423.161.31-1.78-2.33
Total Shareholders Equity7.9715.0423.161.31-1.78-2.33
Accumulated Minority Interest0.000.000.002.052.161.94
Total Equity7.9715.0423.163.370.38-0.39
Total Liabilities & Stockholders Equity59.8970.1270.4165.9873.5673.61
Book Value Per Share0.170.320.500.03-0.04-0.05
Tangible Book Value Per Share-0.060.080.26-0.33-0.41-0.42
Full-Time Employees--389---
Price to Book Ratio10.447.27120.88-171.55-254.58-41.84
Return on Assets-31.25-22.04-7.82-6.64-8.63-15.89
Return on Equity-674.34-249.31-63.20---
Return on Invested Capital-53.33-43.20-5.19-53.11-26.7112.97
Quick Ratio0.840.981.180.660.720.77
Current Ratio0.901.041.250.730.770.82

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-7.08-8.8719.94-4.67-1.571.92
Depreciation2.042.00-1.162.992.822.66
Other Funds (Non Cash)1.011.66-16.854.632.482.94
Funds from Operations-4.04-5.211.932.953.737.52
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-2.895.66-5.21-3.104.91-4.45
Cash from Operating Activities-6.930.44-3.28-0.158.643.07
Capital Expenditures-1.63-2.060.64-3.59-3.70-2.87
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.0016.430.000.000.00
Cash from Investing Activities-1.63-2.0617.07-3.59-3.70-2.87
Cash Dividends Paid-0.78-0.78-0.78-0.78-0.78-0.78
Preferred Dividends (Cash Flow)-0.78-0.78-0.78-0.78-0.78-0.78
Change in Capital Stock0.000.080.009.190.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.080.009.190.000.00
Proceedsfrom Stock Options0.000.008.720.000.000.00
Issuance or Reduction of Debt, Net0.000.000.00-16.67-2.050.00
Change in Long Term Debt0.000.000.00-16.67-2.050.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.00-16.67-2.050.00
Net Financing Active Other Cash Flow0.000.00-0.01-0.45-0.28-0.04
Other Financing Activities Uses0.000.00-0.01-0.45-0.28-0.04
Cash from Financing Activities-0.78-0.70-0.79-8.70-3.10-0.81
Net Change in Cash-9.34-2.3113.00-12.441.83-0.61
Free Cash Flow-6.990.34-3.44-0.947.842.95
Price to Free Cash Flow-245.3548.2838.7840.9122.88

Revenue breakdown

Medifast Collaboration2024: 5.00M
Telehealth2024: 82.14M 2025: 80.79M
Telehealth Subscription2024: 67.68M 2025: 113.27M
United States2024: 154.82M 2025: 194.06M
Medifast Collaboration2024: 5.00M
Telehealth2024: 82.14M 2025: 80.79M
Telehealth Subscription2024: 67.68M 2025: 113.27M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3018.48%7.2M39.2M830.98K
2026-10-1518.89%7.4M39.2M853.03K
2026-09-3019.29%7.6M39.2M880.51K
2026-09-1518.88%7.4M39.2M946.16K
2026-08-3118.47%7.2M39.2M930.84K
2026-08-1417.72%6.9M39.2M989.94K
2026-07-3119.16%7.6M39.5M942.24K
2026-07-1517.98%7.1M39.6M1.05M
2026-06-3016.14%6.4M39.6M1.07M
2026-06-1514.81%5.9M39.6M1.08M
2026-05-2914.12%5.6M39.6M1.24M
2026-05-1514.76%5.9M39.6M1.24M
2026-04-3015.93%6.4M39.9M1.21M
2026-04-1515.04%6.0M39.6M1.12M
2026-03-3115.73%6.2M39.7M1.16M
2026-03-1315.85%6.3M39.7M1.20M
2026-02-2716.24%6.5M39.8M1.07M
2026-02-1314.38%5.7M39.8M1.29M
2026-01-3013.43%5.3M39.4M1.32M
2026-01-1512.45%4.9M39.4M1.29M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.000.500.950.705.95615.000.000.908-0.0080.000
call2.000.100.200.112.6342740.000.456-0.0160.001
call3.000.000.050.053.8441,3460.000.292-0.0190.001
call4.000.000.150.053.5981,9910.000.125-0.0110.001
call5.000.000.050.034.1473680.000.113-0.0120.001
call6.000.000.050.054.6253,4190.000.105-0.0120.001
call7.000.000.050.055.0131100.000.100-0.0130.000
call8.000.000.150.055.52029.000.000.096-0.0140.000
call9.000.000.150.355.8121.000.000.093-0.0150.000
call10.000.000.150.056.0278.000.000.090-0.0150.000
put1.000.000.050.043.1933200.00-0.093-0.0080.000
put2.000.250.500.253.1071740.00-0.544-0.0160.001
put3.001.051.501.075.0932,4370.00-0.847-0.0090.001
put4.002.052.501.736.0631490.00-0.875-0.0110.001
put5.003.003.502.746.8257.000.00-0.887-0.0120.001
put6.004.004.503.007.4122.000.00-0.895-0.0130.001
put7.005.005.502.587.8880.000.00-0.900-0.0130.000
put8.006.006.504.648.2870.000.00-0.904-0.0130.000
put9.007.007.500.008.6300.000.00-0.907-0.0140.000
put10.008.008.500.008.9310.000.00-0.910-0.0140.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-09NT 10-Q2026-09-30SEC
2026-10-07SCHEDULE 13G/ASEC
2026-09-25S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-09-158-KCurrent report2026-09-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-05-04SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-134/A2024-12-02SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-05-04SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-07-08SCHEDULE 13GSEC
2026-06-228-KCurrent report2026-06-22SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-033Initial statement of beneficial ownership of securities2026-06-01SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-05-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-068-KCurrent report2026-05-06SEC
2026-04-30ARSAnnual report to security holders. 2025-12-31SEC
2026-04-30DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-30DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-30DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-04-30SEC
2026-04-01S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-04-014Statement of changes in beneficial ownership of securities2026-03-30SEC
2026-04-013Initial statement of beneficial ownership of securities2026-03-16SEC
2026-04-013Initial statement of beneficial ownership of securities2026-03-16SEC
2026-03-23144Filing for proposed sale of securities under Rule 144.SEC
2026-03-188-KCurrent report2026-03-16SEC
2026-03-1010-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120054.16K1
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.6.27%
FEDERATED HERMES, INC.5.68%
VANGUARD CAPITAL MANAGEMENT LLC3.59%
STATE STREET CORP2.73%
RENAISSANCE TECHNOLOGIES LLC2.23%
GEODE CAPITAL MANAGEMENT, LLC2.21%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.1.86%
BRC Group Holdings, Inc.1.32%
AQR CAPITAL MANAGEMENT LLC1.28%
MARSHALL WACE, LLP1.15%

Funds

Fund% owned
Federated Hermes MDT Small Cap Core Fund3.28%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.53%
iShares Russell 2000 ETF2.16%
Federated Hermes MDT Small Cap Growth Fund1.65%
Bridge Builder Small/Mid Cap Growth Fund1.42%
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF1.10%
VANGUARD EXTENDED MARKET INDEX FUND0.98%
Fidelity Small Cap Index Fund0.91%
Royce Small-Cap Opportunity Fund0.61%
iShares Russell 2000 Growth ETF0.59%

OakChart. LFMD. Cached 15 minutes.